Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ricevuto

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
La Clinica Terapeutica|March 15, 1990
[Medical emergencies in oncology: hypercalcemia. II. Diagnosis and therapy]C Ficorella, S Tomao, P Cagnazzo, et al.
Critical Reviews in Oncology/Hematology|December 30, 2015
Tailoring the dosing schedule of nab-paclitaxel in metastatic breast cancer according to patient and disease characteristics: Recommendations from a panel of expertsG Arpino, F Marmé, J Cortés, et al.
Tumori|May 9, 2002
[Oxaliplatin: preclinical in vitro studies]P Marchetti, G Carlo, A Cappellini, et al.
American Journal of Clinical Oncology|December 1, 1992
Advanced non-small-cell lung cancer (NSCLC) treated with folinic acid (F), fluorouracil (FU), vincristine (O), and mitomycin-C (Mi), (F-FOMi)C Barone, A Astone, A Cassano, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 7, 2009
Sorafenib as a feasible therapeutic option in haemophiliacs with hepatocellular carcinomaM Lapecorella, M Napolitano, M Tudini, et al.
Biomed Research International|June 28, 2014
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancerA Irelli, G Bruera, K Cannita, et al.
Tumori|June 30, 1990
Role of immunoscintigraphy in clinical assessment of gastrointestinal tumorsC Barone, E Ricevuto, C Garufi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Diagnostic strategy for analytical scanning of BRCA1 gene by fluorescence-assisted mismatch analysis using large, bifluorescently labeled ampliconsE Ricevuto, H Sobol, D Stoppa-Lyonnet, et al.
Oncology|January 1, 1991
Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II studyC Barone, A Cassano, A Astone, et al.
British Journal of Cancer|November 10, 2011
Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patientsS Romano, S Fratini, E Ricevuto, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
La Clinica Terapeutica|March 15, 1990
[Medical emergencies in oncology: hypercalcemia. II. Diagnosis and therapy]C Ficorella, S Tomao, P Cagnazzo, et al.
Critical Reviews in Oncology/Hematology|December 30, 2015
Tailoring the dosing schedule of nab-paclitaxel in metastatic breast cancer according to patient and disease characteristics: Recommendations from a panel of expertsG Arpino, F Marmé, J Cortés, et al.
Tumori|May 9, 2002
[Oxaliplatin: preclinical in vitro studies]P Marchetti, G Carlo, A Cappellini, et al.
American Journal of Clinical Oncology|December 1, 1992
Advanced non-small-cell lung cancer (NSCLC) treated with folinic acid (F), fluorouracil (FU), vincristine (O), and mitomycin-C (Mi), (F-FOMi)C Barone, A Astone, A Cassano, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 7, 2009
Sorafenib as a feasible therapeutic option in haemophiliacs with hepatocellular carcinomaM Lapecorella, M Napolitano, M Tudini, et al.
Biomed Research International|June 28, 2014
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancerA Irelli, G Bruera, K Cannita, et al.
Tumori|June 30, 1990
Role of immunoscintigraphy in clinical assessment of gastrointestinal tumorsC Barone, E Ricevuto, C Garufi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Diagnostic strategy for analytical scanning of BRCA1 gene by fluorescence-assisted mismatch analysis using large, bifluorescently labeled ampliconsE Ricevuto, H Sobol, D Stoppa-Lyonnet, et al.
Oncology|January 1, 1991
Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II studyC Barone, A Cassano, A Astone, et al.
British Journal of Cancer|November 10, 2011
Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patientsS Romano, S Fratini, E Ricevuto, et al.
Pageof 5